PhD Uroš Urleb
no.: 01878

researcher – active in research organisation

Research activity

Code	Science	Field	Subfield
1.09.00	Natural sciences and mathematics	Pharmacy

Keywords

Medicinal chemistry, drug design, peptidomimetics, drug analysis, nir spectroscopy

Bibliography Representative bibliographic units | Personal| COBISS+

source: COBISS

source: SICRIS

Evaluation (rules)

Evaluation of bibliographic research performance indicators according to ARIS methodology

source: COBISS

source: ARIS

Points

10.74

A''

0

A'

0

A1/2

0

CI10

723

CImax

142

h10

14

A1

0.03

A3

0

Data for the last 5 years (citations for the last 10 years) on September 28, 2023; A3 for period 2017-2021 (update for tender in 2022: NO)

Data for ARIS tenders ( 14.06.2023 – Target research programmes, archive )

Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases

source: WoS

source: Scopus

source: COBISS

Database	Linked records	Citations	Pure citations	Average pure citations
WoS	102	1,377	1,072	10.51
Scopus	107	1,593	1,272	11.89

Audiovisual sources

no.	Title (with video link)	Event	Source
1.

Mentoring junior researchers

source: ARIS

no.	Name and surname	Type	Period	Code
1	PhD Tomaž Bratkovič	Uniform doctoral studies	1/1/2003 - 8/31/2005	23598
2	PhD Aleš Obreza	Doctoral degree	11/1/1998 - 5/31/2002	19061
3	KATARINA VERHNJAK	Master's degree	6/1/1992 - 5/31/1995	12633
4	VESNA LESKOVŠEK	Master's degree	4/1/1992 - 3/31/1995	12632

Doctoral dissertations and other final papers Show

source: COBISS

Employments

source: ARIS

Type of employment	Research org.	Research group
Full time employment (100%, RD:100%)	Lek Pharmaceutical Company d.d.	Raziskovalna skupina Lek (Slovene)
Full time employment (20%, RD:0%)	University of Ljubljana, Faculty of Pharmacy	Chair for Pharmaceutical Chemistry

Research projects Legend

source: ARIS

no.	Code	Title	Period	Head	No. of publications
1.	L2-1112	Knowledge technology approaches in drug discovery: analysis and experiment planning in high-throughput genetics	2008	PhD Blaž Zupan	2,979
2.	L1-9596	Molecular mechanism of novel hypolipidemics	2007 - 2008	PhD Uroš Urleb	1,728
3.	J1-7584	Novel Mur ligase inhibitors	2005 - 2008	PhD Uroš Urleb	1,122
4.	Z1-7586	Development of Mur Ligase Inhibitors as Novel Antibacterial Agents	2005 - 2007	PhD Uroš Urleb	402
5.	L1-6707	Design, synthesis and test of potencial hypolipidemic drugs with a new target	2004 - 2007	PhD Uroš Urleb	3,311
6.	L3-5084	Peptidominetiki - inhibitorji koagulacije krvi in agregacije trombocitov (Slovene)	2003 - 2005	PhD Mojca Stegnar	5,450
7.	L1-3261	Development of biologicaly active peptidomimetics	2002 - 2003	PhD Uroš Urleb	2,040
8.	L1-0469	Optimization of MDP and TNF analogues having therapeutic potential	1998 - 2000	PhD Anton Štalc	6,103
9.	J1-8889	Mimetics of biologically active peptides: Strategies of design and synthesis	1997 - 1999	PhD Danijel Kikelj	3,791
10.	L1-7379	Raziskave možnih implementacij dezmuramilnih analogov MDP in rekombinatnih analogov TNF-a v terapiji (Slovene)	1996 - 1998	PhD Anton Štalc	5,917
11.	J1-7053	Selektivni ligandi: sinteza, interakcije z makromolekulami in transport v biosistemih (Slovene)	1995 - 1998	PhD Aleš Mrhar	7,006

ARIS research and infrastructure programmes Legend

source: ARIS

no.	Code	Title	Period	Head	No. of publications
1.	P1-0340	Design and preclinical development of novel drugs	2014 - 2017	PhD Uroš Urleb	1,523
2.	P1-0340	Načrtovanje in predklinični razvoj novih zdravilnih učinkovin (Slovene)	2009 - 2013	PhD Uroš Urleb	913
3.	P1-0340	Načrtovanje in predklinični razvoj novih zdravilnih učinkovin (Slovene)	2006 - 2008	PhD Uroš Urleb	1,555
4.	P1-0208	Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)	2004 - 2005	PhD Danijel Kikelj	5,836

We were not given permission by the researcher to publish data.